Project Details
Description
A global phase 3, randomised, double-blind and placebo-controlled study evaluating the efficacy and safety of etavopivat in adolescents and adults with sickle cell disease
Status | Active |
---|---|
Effective start/end date | 9/25/24 → 9/24/35 |
Funding
- NOVO NORDISK, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.